Clinical trials
Neurosciences clinical trials
Below are recruiting neurosciences clinical trials, each written for real people, not researchers. We’re tracking 66 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07637422Enrolling by invitation
Online social skills training for healthcare workers
This study tests an online program designed to help healthcare professionals like doctors, nurses, and therapists improve their social skills and emotional well-being through guided practice sessions. The training may help you communicate better with patients and feel less stressed at work.
Berlin, State of BerlinAges 18–68 - NCT06167330Recruiting
Titan trial: Reducing phantom limb pain
This trial tests a new method to reduce phantom limb pain (pain felt in a missing limb) using gentle electrical stimulation and simple mental exercises. It is for people with one-sided amputations who have had phantom limb pain for at least three months and still have pain episodes now.
Randwick, New South WalesAges 18 years+ - NCT07590323Recruiting
Blood Flow Restriction Training for Knee Osteoarthritis
This study tests whether a special training method called blood flow restriction (BFR)—which uses a cuff to safely limit blood flow while you exercise—can help reduce knee osteoarthritis pain and improve function. You'll do supervised exercises three times a week for 8 weeks.
Ha'il, Ha'il RegionAges 40–70 - NCT07565428RecruitingPhase 3
Study of roluperidone for negative symptoms of schizophrenia
This trial tests a new medicine called roluperidone for people with schizophrenia who have ongoing negative symptoms (like low motivation or social withdrawal) but stable positive symptoms (like hallucinations). It aims to see if the drug helps with these symptoms and if it can reduce the chance of relapse compared to other medications.
Bellflower, CaliforniaAges 18–55 - NCT07553637RecruitingPhase 2
ALTO-207 for Adults With Hard-to-Treat Depression
This study tests whether a new medication called ALTO-207 can help people with depression that hasn't improved with standard antidepressants. You may qualify if you've tried multiple antidepressants without enough relief and are willing to add this experimental treatment to your current medication.
Birmingham, AlabamaAges 18–75 - NCT07527663Recruiting
GyroStim therapy for persistent symptoms after concussion
This study tests whether GyroStim—a specialized rotating chair therapy—can help reduce dizziness, balance problems, and thinking difficulties that last more than 4 weeks after a head injury. GyroStim is designed to retrain how your brain and inner ear work together.
Appleton, WisconsinAges 18 years+ - NCT07489651RecruitingPhase 2
New treatment for generalized anxiety disorder
This trial tests a new medication called RE104 for people with generalized anxiety disorder (GAD). The goal is to see if it helps reduce anxiety symptoms safely.
Birmingham, AlabamaAges 18–74 - NCT03347786RecruitingPhase 1/Phase 2
Verapamil to protect the brain after acute stroke
This trial tests whether verapamil, a common blood-pressure/heart medicine, can help protect the brain after an acute ischemic stroke. It may improve recovery outcomes by supporting the brain’s ability to heal, especially early after stroke symptoms begin.
Atlantic City, New JerseyAges 18–80 - NCT07306312Enrolling by invitation
How thoughts affect low back pain with manual therapy
This study looks at how your thoughts and feelings about your chronic low back pain affect your pain and ability to move, during a course of manual therapy (hands-on treatment by a therapist). It may help you understand if your mindset influences your recovery.
AthensAges 18–65 - NCT06892028Recruiting
EEG-guided brain stimulation for PTSD in veterans and first responders
This study tests if personalized brain stimulation guided by your brain waves (EEG) can reduce PTSD symptoms. It's for veterans and first responders who have had PTSD for at least 6 months.
Dayton, OhioAges 22–65 - NCT07205991Recruiting
Ways to stick with a back-pain mobile app
This trial tests strategies to help people with chronic low back pain use a mobile health app consistently. If you have ongoing back pain and participated in the NOTUS trial, this study might show you better ways to stay engaged with the app.
Sydney, New South WalesAges 18 years+ - NCT07055971Enrolling by invitation
Pain education and brain training for fibromyalgia
This trial tests whether a program that teaches you about pain and helps your brain control pain better can improve fibromyalgia symptoms. It also looks at how emotions play a role.
Granada, AndalusiaAges 18 years+ - NCT07051577Recruiting
Brain-Based Training for Young Archers
This study tests a special brain-based training program for young archers aged 15–18. The goal is to see if these exercises can improve your shooting accuracy and how your muscles work.
Istanbul, IstanbulAges 15–18 - NCT07019493Recruiting
Young stroke recovery study for ages 18 to 55
This study looks at how young adults recover from a stroke. Researchers want to learn more about what helps recovery in the first few months after a stroke.
Heidelberg, VictoriaAges 18–55 - NCT07002034RecruitingPhase 2
RE104 for adjustment disorder related to cancer or other serious illnesses
This trial is testing a new medication (RE104) for people who have adjustment disorder with depressed mood or anxiety because of a serious medical condition like cancer, ALS, MS, Parkinson's, or lung fibrosis. It's a study to see if the drug is safe and reduces symptoms.
Birmingham, AlabamaAges 18–80 - NCT06984354Recruiting
Digital treatments for chronic low back pain
This trial tests a smartphone app to help people with long-term low back pain. It aims to see if digital treatments can reduce pain and improve daily function.
Randwick, New South WalesAges 18 years+ - NCT06963775Enrolling by invitation
Brain injury study using magnetic brain stimulation
This study uses a non-invasive magnetic stimulation technique to measure brain activity in people who have had a traumatic brain injury (TBI). It aims to see if this tool can help doctors better understand and track recovery after a head injury.
Philadelphia, PennsylvaniaAges 18 years+ - NCT06894225RecruitingPhase 2
Targeted drug for recurrent brain cancer with STAT3 marker
This trial tests a new drug called ACT001 for people with recurrent glioblastoma (a type of brain cancer) whose tumors have a specific marker (STAT3-high). The drug targets that marker to try to stop the tumor from growing.
SingaporeAges 21 years+ - NCT06795243Recruiting
Physical therapy for endometriosis and exercise adherence
This study tests whether physical therapy (exercise for your muscles) can help with endometriosis symptoms and how well people stick with the program. If you have endometriosis and can do light strength exercises, you may be able to join.
SevilleAges 18 years+ - NCT05922878RecruitingPhase 2
ALTO-300 study for moderate to severe depression
This trial tests ALTO-300 as an add-on treatment for people with moderate to severe major depressive disorder (MDD). It aims to see whether ALTO-300 helps improve depression symptoms when you’re already on a stable antidepressant.
Phoenix, ArizonaAges 18–70 - NCT06716489Recruiting
Exercise study for women with migraine
This study tests whether aerobic exercise can help reduce migraine symptoms and improve how your body senses and responds to pain. It is specifically for women aged 18–48 who have migraine headaches 3–8 days per month.
Ribeirão Preto, São PauloAges 18–48 - NCT06702189Recruiting
EXOPULSE Mollii Suit for low back pain
This trial tests a special suit (EXOPULSE Mollii) to see if it helps relieve low back pain. It may be an option if you've had back pain for at least 3 months and are not planning surgery.
Créteil, VAL DE MarneAges 18–75 - NCT06696001Recruiting
Brain Study of Talk Therapy for Depression
This study looks at how your brain works during talk therapy for depression. It aims to find out how therapy helps you feel better so that future treatments can be more personalized.
Chapel Hill, North CarolinaAges 18–30 - NCT06656416RecruitingPhase 2
Study of ALTO-100 for bipolar depression
This study tests an investigational drug called ALTO-100 for people with bipolar disorder who are currently experiencing depression. It aims to see if ALTO-100 can help improve depressive symptoms when added to your current mood stabilizer or antipsychotic medication.
Birmingham, AlabamaAges 18–70
Hear when a new Neurosciences trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for neurosciences?
- Yes. Clin2 currently lists 66 recruiting neurosciences studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a neurosciences trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a neurosciences trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.